Mazzieri, R., Jurukovski, V., Obata, H., Sung, J., Platt, A., Annes, E., Karaman Jurukovska, N., Gleizes, P. E. and Rifkin, D. B. (2005). Expression of truncated latent TGF-β-binding protein modulates TGF-β signaling. J. Cell Sci.118, 2177-2187.
In the title and the summary of this article, latent TGF-β-binding protein was incorrectly referred to as latent TGF-β protein and latent transforming binding protein, respectively. This error appeared in the e-press version of this article. The correct title and summary are shown below.
Expression of truncated latent TGF-β-binding protein modulates TGF-β signaling
Roberta Mazzieri1,*,‡, Vladimir Jurukovski1,*,§, Hiroto Obata1,¶, Joanne Sung1, Alec Platt1,**, Eric Annes1,‡‡, Nevena Karaman-Jurukovska2, Pierre-Emmanuel Gleizes1,§§ and Daniel B. Rifkin1,3,¶¶
Transforming growth factor-β is released from most cells as an inactive complex consisting of transforming growth factor-β, the transforming growth factor-β propeptide and the latent transforming growth factor-β-binding protein. We studied the role of latent transforming growth factor-β-binding protein in modulating transforming growth factor-β availability by generating transgenic mice that express a truncated form of latent transforming growth factor-β-binding protein-1 that binds to transforming growth factor-β but is missing the known N- and C-terminal matrix-binding sequences. As transforming growth factor-β is an inhibitor of keratinocyte proliferation and is involved in the control of hair cycling, we overexpressed the mutated form of latent transforming growth factor-β-binding protein under the control of the keratin 14-promoter. Transgenic animals displayed a hair phenotype due to a reduction in keratinocyte proliferation, an abbreviated growth phase and an early initiation of the involution (catagen) phase of the hair cycle. This phenotype appears to result from excess active transforming growth factor-β, as enhanced numbers of pSmad2/3-positive nuclei are observed in transgenic animal skin. These data suggest that the truncated form of latent transforming growth factor-β-binding protein-1 competes with wild-type latent transforming growth factor-β-binding protein for binding to latent transforming growth factor-β-binding protein for binding to latent transforming growth factor-β, resulting in latent transforming growth factor-β complexes that fail to be targeted correctly in the extracellular matrix. The mislocalization of the transforming growth factor-β results in inappropriate activation and premature initiation of catagen, thereby illustrating the significance of latent transforming growth factor-β-binding protein interaction with transforming growth factor-β in the targeting and activation of latent transforming growth factor-β in addition to previously reported effects on small latent complex secretion.